Cell Impact delivers flow plates and test tools to a major player in Asia


Werte in diesem Artikel
Aktien

238.30 EUR 0.40 EUR 0.17 %

KARLSKOGA, Sweden, May 19, 2025 /PRNewswire/ -- Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's attractive offering and its unique forming technology.

Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's attractive offering and Cell Impact Forming™, its unique forming technology that is significantly more scalable and cost-efficient compared to conventional forming methods.

The agreement is a follow-up order from a customer with whom Cell Impact has previously conducted development projects.

"The tests of our forming technology conducted by this customer have been successful, which has laid the foundation for today's agreement. This is a process we have seen before. Successful tests of Cell Impact Forming™ lead to new business, which in turn is a prerequisite for future volume production," says Mr. Daniel Vallin, CEO of Cell Impact.

The order includes both flow plates and a test tool that will be used to manufacture customized flow plates. Delivery will take place during the second quarter, and the order value amounts to MSEK 0.6.

Photo: https://mma.prnewswire.com/media/2690599/Cell_Impact.jpg

For more information, please contact:
Daniel Vallin
CEO and IR contact, Cell Impact AB (publ)
+46730686620 or daniel.vallin@cellimpact.com 

About Cell Impact

Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell and electrolyzer manufacturers. The company has developed and patented a unique method for high velocity forming, Cell Impact Forming™ which is significantly more scalable and cost-efficient compared to conventional forming methods. Cell Impact Forming is an environmentally friendly forming technology that consumes no water and very little electrical power.

The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company's Certified Advisor (CA).

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cell-impact-delivers-flow-plates-and-test-tools-to-a-major-player-in-asia-302458870.html

SOURCE Cell Impact

Aktuelle The Cigna Group Registered Aktie News

Werbung

The Cigna Group Registered Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Cigna Group Registered nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
20.07.18 Express Scripts Neutral Robert W. Baird & Co. Incorporated
08.03.18 Express Scripts Equal Weight Barclays Capital
08.03.18 Cigna Overweight Barclays Capital
31.01.18 Express Scripts Outperform RBC Capital Markets
15.12.17 Express Scripts Outperform Robert W. Baird & Co. Incorporated

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.